A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
Clinical trial NCT01875003 · TERMINATED
Trial details
- NCT number
- NCT01875003
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-13
- Primary completion
- 2016-12-28
- Enrollment
- 346
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.